Has the GEM-CESAR study demonstrated that early intervention in SMM should be a new SOC?

The Multiple Myeloma Hub are pleased to present a series of expert interviews from the 61st American Society of Hematology (ASH) meeting in Orlando, US. In this video, María Victoria Mateos, University Hospital of Salamanca, Salamanca, ES, answers the question: Has the GEM-CESAR study demonstrated that early intervention in smoldering multiple myeloma should be a new standard of care?

María Victoria Mateos talks about the results of the GEM-CESAR study that was conducted in high-risk smoldering multiple myeloma patients with the aim to offer a curative option for these asymptomatic patients. She discusses the treatment regimen of the study arms and states the MRD-status was monitored to measure patient response to treatment.